Literature DB >> 26365059

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.

Guopei Luo1, Zuqiang Liu2, Meng Guo3, Kaizhou Jin2, Zhiwen Xiao2, Liang Liu1, Chen Liu1, Jin Xu1, Quanxing Ni1, Jiang Long4, Xianjun Yu5.   

Abstract

BACKGROUND: Incidentally discovered, nonfunctioning pancreatic endocrine tumors (NF-pNETs) are being increasingly diagnosed with the widespread use of imaging examination. The objective of this study was to analyze the different clinicopathologic and imaging features between incidentally discovered and symptomatic NF-pNETs.
METHODS: From March 2010 to October 2014, we retrospectively analyzed 102 patients with pathologically confirmed sporadic NF-pNETs, among which 49 (48.0%) had lesions that were discovered incidentally. Differences in clinicopathologic features and various computerized tomography (CT) and endoscopic ultrasonography (EUS) findings were evaluated between incidental and symptomatic NF-pNETs.
RESULTS: Among 102 patients with NF-pNETs, 49 (48.0%) had lesions that were discovered incidentally. Incidental NF-pNETs were more highly associated with low tumor grades, stages and lymphatic metastasis compared with symptomatic tumors (p = 0.007, 0.029 and 0.003, respectively). Moreover, incidental NF-pNETs had a lower rate of hypoenhancement (p = 0.018), main pancreatic duct dilatation (p = 0.043), and unclear border (p = 0.022). In addition, hypoechoic lesion was the most common and had a slightly higher rate in symptomatic tumors (p = 0.032).
CONCLUSIONS: Incidental NF-pNETs are associated with lower rates of aggressive behaviors of clinicopathologic and imaging features compared with symptomatic tumors.
Copyright © 2015 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinicopathologic features; Imaging features; Incidental; Non-function pancreatic neuroendocrine tumors; Prognosis; Symptomatic

Mesh:

Year:  2015        PMID: 26365059     DOI: 10.1016/j.pan.2015.08.009

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  3 in total

Review 1.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2019-11-27       Impact factor: 4.512

2.  Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.

Authors:  Guopei Luo; Chen Liu; He Cheng; Kaizhou Jin; Meng Guo; Yu Lu; Jiang Long; Jin Xu; Quanxing Ni; Jie Chen; Xianjun Yu
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

Review 3.  Literature review of imaging, pathological diagnosis, and outcomes of metachronous lung and pancreatic metastasis of cecal cancer.

Authors:  Xiang Wu; Shuping Zhou; Xinhua Zhou; Xiao Xu; Luoluo Wang; Yi Ruan; Jun Lu; Haili Li; Hongfeng Xu; Xinyi Ma; Hong Li
Journal:  World J Surg Oncol       Date:  2022-10-17       Impact factor: 3.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.